SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer

Background: Taxanes are frontline chemotherapeutic drugs for patients with triple-negative breast cancer (TNBC); however, chemoresistance reduces their effectiveness. We hypothesized that the molecular profiling of tumor samples before and after neoadjuvant chemotherapy (NAC) would help identify gen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Liu, Xi-Yu, Jiang, Wang, Ma, Ding, Ge, Li-Ping, Yang, Yun-Song, Gou, Zong-Chao, Xu, Xiao-En, Shao, Zhi-Ming, Jiang, Yi-Zhou
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532662/
https://ncbi.nlm.nih.gov/pubmed/33042263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.45207
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars